| Name | Agency | Title |
|---|
| Bloomenthal, Dr. Dena | Funded by the Vancouver Foundation | The Effect of Fetal Factor V Leiden Carriage on Pregnancy Complications. A prospective cohort study presently recruiting subjects. |
| Brotto, Dr. Lori A. | Leslie Diamond Foundation | Ending Unvoiced Pain: A comprehensive, multidisciplinary program for women’s genital pain. |
| Brotto, Dr. Lori A. | British Columbia Medical Services Foundation Grant | Group Psychoeducational Treatment for Women With Sexual Arousal and Desire Difficulties |
| Brotto, Dr. Lori A. | Hampton Research Fund Endowment | Sex, memory, and culture |
| Butler, Dr. Blair | March of Dimes Foundation | A Novel Strategy to Reduce Morbidity Associated With Preterm Birth: Metagenomic Profiles of Vaginal Microbiota as Predictors of Neonatal Otucomes Following Preterm Premature Rupture of the Membrances |
| Cheung, Dr. Anthony P. | CIHR | The role of women's knowledge and beliefs about ART in their decisions to delay childbearing |
| Christilaw, Dr. Jan E. | CIHR | Maternal Child and Health Research Training Program |
| Dahlgren, Dr. Leanne S. | CIHR | Pregnancy, beta-interferon exposure, and long-term disability in Multiple Sclerosis. |
| Dahlgren, Dr. Leanne S. | Canadian Institutes of Health Research (CIHR) | Fetal and Infant Mortality and Serious Neonatal Morbidity among Status Indians in British Columbia. |
| Delisle, Dr. Marie-France | NIH | Asymptomatic HSV Infection in Pregnancy |
| Ehlen, Dr. Thomas G. | National Cancer Institute of Canada | NCIC randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer. |
| Ehlen, Dr. Thomas G. | NCIC | A phase III randomized study of Cisplatin alone versus a combination of etoposide, ifofamide, and cisplating(VIP) in the treatment of persistent, recurrent or advanced squamous or adnosquamous cell carcinoma of the cervix. (NCIC CX3) |
| Ehlen, Dr. Thomas G. | National Cancer Institute of Canada | An international multi-centre randomized phase iii study comparing upfront debulking surgery versus neo-adjuvant chemotherapy in patients with stage IIIc or IV epithelial ovarian carcinoma |
| Ehlen, Dr. Thomas G. | National Cancer Institute of Canada | International randomized phase III trial of Paclitaxel/Epirubicin/Carboplatin (TEC) versus Paclitaxel/Carboplatin (TC) in the initial treatment of women with advanced ovarian cancer |
| Ehlen, Dr. Thomas G. | Ampersand Medical Inc. | Clinical evaluation of InPath SBT system for adjunctive screening of cervical cytology specimens |
| Ehlen, Dr. Thomas G. | Ontario Clinical Oncology Group | Randomized trial of immediate treatment versus follow up of biopsy proven CIN I |
| Ehlen, Dr. Thomas G. | Knoll/BASF | A Phase II study to determine the efficacy and safety of ELINAFIDE as salvage therapy for patients with advanced carcinoma of the ovary |
| Ehlen, Dr. Thomas G. | National Cancer Institute of Canada | A comparison between BAY 12-9566 and placebo as consolidation after standard chemotherapy in patients with epithelial ovarian cancer |
| Ehlen, Dr. Thomas G. | | A phase II, multicenter, non-randomized study of taxol in patients with ovarian cancer previously treated with platinum therapy. |
| Gagnon, Dr. Alain L. | CIHR | Twin Birth Study [950.00 per subject] |
| Geoffrion, Dr. Roxana | American Urogynecologic Society | Surgical Education Multicentre Randomized Controlled Trial - Mental Imagery |
| Geoffrion, Dr. Roxana | UBC FoM | Summer Student Research Project - Clinical Characteristics & Treatment outcomes of women unable or unwilling to use a pessary for the treatment of pelvic organ prolapse |
| Geoffrion, Dr. Roxana | Royal College Medical Education | PROMOTE: Procedure Specific Resident Modular Objective Training & Evaluation |
| Giesbrecht, Dr. Ellen M. | CIHR | The CHIPS Trial |
| Hammond, Dr. Geoffrey L. | | |
| Hammond, Dr. Geoffrey L. | CIHR Operating Grant | Sex hormone-binding globulin:Beyond plasma transport |
| Heywood, Dr. Mark S. | National Cancer Institute | Efficacy of psychoeducation and Zestra for sexual dysfunction after radiation therapy |
| Heywood, Dr. Mark S. | Canadian Institue of Health Research | Advanced ovarian cancer and sexuality: Development of a psychoeducational intervention to reduce distress |
| Heywood, Dr. Mark S. | National Cancer Institute of Canada | Advanced ovarian cancer and sexuality: Development of a psychoeducational intervention to reduce distress |
| Heywood, Dr. Mark S. | Cancer Care Manitoba | Local pilot study of IFN-alpha and Tamoxifen in resistant ovarian cancer |
| Heywood, Dr. Mark S. | National Cancer Institute of Canada | Upfront debulking vs upfront chemotherapy for ovarian cancer |
| Heywood, Dr. Mark S. | National Cancer Institute of Canada | Cisplatin/topotecan/carbo/taxol vs taxol/carbo for advanced ovarian cancer |
| Heywood, Dr. Mark S. | Schering | Caelyx and carboplatin in relapsed ovarian cancer |
| Heywood, Dr. Mark S. | GlaxoSmithKline | Topotecan and cisplatin in relapsed squamous cervix |
| Joseph, Dr. K.S. | CIHR | Fetal and infant mortality and serious neonatal morbidity among Status Indians in British Columbia. |
| Joseph, Dr. K.S. | CIHR | CIHR Team in Maternal-Infant Care: Translating knowledge into improved care. |
| Joseph, Dr. K.S. | CIHR | The twin birth study: a multicentre randomized controlled trial comparing planned vaginal birth to elective cesarean section of twins more than or equal to 32 weeks gestation. |
| Leung, Dr. Peter C. | CFRI | Distinguished Scientist Award |
| Leung, Dr. Peter C. | CIHR | Biological actions of GnRH in human implantation and placentation |
| Leung, Dr. Peter C. | CIHR | Autocrine and paracrine control of ovarian granulose cell function |
| Lim, Dr. Kenneth I. | BCCH Research Foundation | Perinatal Research Fund [42,000 total] |
| Liston, Dr. Robert M. | BC Medical Services Foundation | Effect of Fetal Carriage of Factor V Leiden on the Expression of Pregnancy Complications |
| Liston, Dr. Robert M. | CIHR | A mixed-methods study of the experience of Canadian maternity care providers and key informants with planned home birth |
| Liston, Dr. Robert M. | CIHR | Trainees in Maternity Care: what do they believe about birth and how do they select their profession? |
| Liston, Dr. Robert M. | March of Dimes | A Novel Strategy to Reduce Morbidity Associated with Preterm Birth: Metagenomic Profiles of Vaginal Microbiota as Predictors of Neonatal Outcomes Following Preterm Premature Rupture of the Membranes (PPROM). |
| Ma, Dr. Sai | Canadian Institutes of Health Research | Chromosomal and epigenetic abnormalities after ICSI treatment for male infertility. |
| Ma, Dr. Sai | Canadian Institutes of Health Research | Investigation of meiotic defects in infertile men undergoing assisted reproductive technologies. |
| Ma, Dr. Sai | Canadian Institutes of Health Research (CIHR) | Investigation of meiotic defects as an underlying cause of male infertility |
| Mayer, Dr. Chantal | Women's Health Research Institute | Research Capacity Building Award. |
| Mayer, Dr. Chantal | Nelly Auersperg Award in Women’s Health Research. | Multivariable risk prediction tool for prolonged pregnancy: a single site pilot study . |
| McAlpine, Dr. Jessica N. | Vancouver Coastal Health Research Institute In it For Li | PARP inhibitors in epithelial ovarian cancer: targeted molecular therapy in BRCA null phenotypes and mechanisms of resistance. [$50,000 per year] |
| McAlpine, Dr. Jessica N. | Merck (US-Investigator Initiated Research Program) | The Impact of Bisphosphonates on bone loss in patients undergoing surgery and postoperative chemotherapy for gynecologic malignancies |
| McAlpine, Dr. Jessica N. | Genzyme Biosurgery | Seprafilm™ for the prevention of intraperitoneal adhesions and improved delivery of therapy in women undergoing surgical staging and intraperitoneal chemotherapy for advanced ovarian cancer (Investigator Sponsored Trial) |
| McAlpine, Dr. Jessica N. | Canadian Institutes of Health Research (CIHR) | Genomic distruption in high-grade serous ovarian carcinomas: steady state or continuous drift? |
| McAlpine, Dr. Jessica N. | Canadian Institutes of Health Research (CIHR) | Intratumoral heterogeneity in high grade serous carcinoma: implications in primary treatment and recurrence. |
| McAlpine, Dr. Jessica N. | VGH Foundation | Ovarian carcinoma from precursor lesion to prevention (PTP) |
| McAlpine, Dr. Jessica N. | CIHR | Selective Excitation Light Fluorescence (SELF) Imaging In Vivo |
| McAlpine, Dr. Jessica N. | CIHR | Randomized Double-Blind Controlled Trial to Evaluate the Efficacy of Adjuvant Propofol Infusion for Post-Operative Nausea and Vomiting (PONV): A Pilot Study. |
| McAlpine, Dr. Jessica N. | Canadian Institutes of Health Research (CIHR) | A study of the immunobiology of an HPV VLP Vaccine in a Cohort of HIV Positive Girls and Women |
| McAlpine, Dr. Jessica N. | Collaborative Health Research Projects (CHRP) | The evolutionary history of high-grade serous ovarian cancer: investigating genomic mechanisms of chemoresistance |
| McAlpine, Dr. Jessica N. | Canadian Institutes of Health Research (CIHR) | Genomic Disruption in High-Grade Serous Ovarian Carcinomas: Steady State or Continuous Drift? |
| McAlpine, Dr. Jessica N. | Martha Piper Research Fund | Selective Excitation Light Fluorescence (SELF) Imaging In Vivo |
| McComb, Dr. Peter F. | Funded by internal research account (BHY) | Is aberrant endometrial development the cause of tubal-cornual polyps? |
| Miller, Dr. Dianne M. | NCIC | NCIC randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer. ($1300/patient) |
| Miller, Dr. Dianne M. | NIH | A phase II clinical trial of anetholtrithione (sialor) in smokers with dysplasia of the bronchial epithelium [$639,670 over 3 yrs] |
| Money, Dr. Deborah M. | CIHR | Emerging Team Grant in Metagenomic Characterization of the Vaginal Microbione |
| Money, Dr. Deborah M. | CIHR | Characterization of maternal immune responses and viral determinants of hepatitis C virus during pregnancy |
| Money, Dr. Deborah M. | | Prospective study of HIV infected pregnant women: obstetrical virologic and neonatal outcomes with multidisciplinary care. [Unfunded] |
| Money, Dr. Deborah M. | GSK | A phase III, double-blind, randomized, controlled study to evaluate the safety, immunogenicity and efficacy of GlaxoSmithKline Biologicals’ HPV-16/18 L1/AS04 vaccine administered intramuscularly according to a three-dose schedule (0, 1, 6 month) in healt |
| Money, Dr. Deborah M. | MSFHR | A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine [$1,600,000 (for 4 years)] |
| Money, Dr. Deborah M. | CIHR | Mechanism of aging following exposure to HIV antiretroviral drugs |
| Money, Dr. Deborah M. | CIHR | A Study of an HPV VLP Vaccine in a Cohort of HIV Positive Girls and Women |
| Money, Dr. Deborah M. | March of Dimes Prematurity Research Initiative | Defining the role of vaginal microbial ecology in preterm birth [$318,000 USD] |
| Money, Dr. Deborah M. | Merck & Co. | A Randomized, International, Double-Blinded Trial, Controlled With GARDASIL |
| Money, Dr. Deborah M. | MSFHR Post-doctoral fellowship award | Reproducitve Trends among HIV Positive Women in BC's HAART era: Examining the interplay between pregnancy, antiretroviral adherence, and HIV disease progression |
| Money, Dr. Deborah M. | CIHR | Metagenomic characterization of the human vaginal microbiome (VOGUE) |
| Money, Dr. Deborah M. | CIHR | Interdisciplinary Women’s Reproductive Health Research Training Program [$1,950,000 (total)] |
| Money, Dr. Deborah M. | CIHR | A Secondary Analysis of Perinatal Complications and Infant Outcomes in First Nations People in BC |
| Money, Dr. Deborah M. | Canadian HIV Trials Network | Canadian Physician Attitudes’ Regarding Pregnancy, Fertility Care, and Assisted Reproductive Technologies for HIV-Positive Individuals |
| Money, Dr. Deborah M. | Merck & Co.Contract | A Randomized, International, Double-Blinded (With In-House Blinding), Controlled With GARDASIL™, Dose-Ranging, Tolerability, Immunogenicity, and Efficacy Study of a Second Generation Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Adminis |
| Money, Dr. Deborah M. | MSFHR (Applied for) | Primary health care, intersectionality and vulnerable and marginalized populations |
| Money, Dr. Deborah M. | MSFHR (Applied for) | Collaborative research group for the study of human vaginal microbiota in health and disease |
| Money, Dr. Deborah M. | MSFHR (Career Investigator) - (Applied for) | Infectious Diseases in Women’s Reproductive Health |
| Money, Dr. Deborah M. | Health Canada - (Applied for) | Analysis of causes of adverse pregnancy and infant health outcomes in First Nations people in British Columbia |
| Money, Dr. Deborah M. | CIHR | Defining the role of vaginal microbial ecology in preterm birth |
| Money, Dr. Deborah M. | CIHR | Understanding HINI immunization knowleged, attitudes and behaviour in pregnant women in B.C. |
| Money, Dr. Deborah M. | Peter Wall Institute for Advanced Studies | HIV - exposed but unifected (HEU) infants: an exploration of the causes of enhanced morbity and mortality. |
| Money, Dr. Deborah M. | CIHR | Canadian HIV Women and Reproductive Health Cohort Study |
| Money, Dr. Deborah M. | CIHR Meeting Planning and Dissemination Grant | Vaginal Microbiome Project Workshop |
| Money, Dr. Deborah M. | CIHR Meeting Planing and Dissemination Grant | Canadian Participation in Reproductive Infectious Diseases Meetings [IDSOG] |
| Money, Dr. Deborah M. | Merck | A Randomized, International, Double-Blinded (With In-House Blinding), Controlled with GARDASIL™, Dose-Ranging, Tolerability, Immunogenicity, and Efficacy Study of a Second Generation Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Adminis |
| Money, Dr. Deborah M. | GSK HPV-067 | A phase lllb, open-label, multi-centre immunization study to evaluate the safety of GlaxoSmithKline (GSK) Biologicals’ HPV-16/18 L1 VLP AS04 vaccine administered intramuscularly according to a 0, 1, 6-month schedule in healthy female subjects who receive |
| Rurak, Dr. Dan W. | MRC* | Part of an MRC Program Grant " The kinetics, effects and toxicology of drugs during pregnancy, the newborn period and childhood", |
| Rurak, Dr. Dan W. | MRC@ | Terminal awards |
| Rurak, Dr. Dan W. | MRC | part of a multidisciplinary research project on psychotropic drug use during and after pregnancy involving pharmacokinetic, newborn biobehavioral and maternal psychological components. |
| Rurak, Dr. Dan W. | CIHR | Fetal Programming of Postnatal Drug Disposition |
| Rurak, Dr. Dan W. | MRC | |
| Sadownik, Dr. Leslie A. | The Terry Fox Foundation | Randomized Controlled trial comparing routine colposcopy to HPV testing to identify persistent or recurrent high grade cervical cancer precursors. Started recruitment June 2010 |
| Sadownik, Dr. Leslie A. | Sponsor Remicalm UC | Measurement of Digital Colposcopy for Fluorescence spectroscopy of Cervical Intraepithelial Neoplasia. 2011 |
| Skoll, Dr. Amanda | Canadian Institutes of Health Research (CIHR) | Placental Insufficiency and Aortic Isthmus Flow (PIAF) |
| Stuart, Dr. Gavin C. | CIHR Operating Grant | A randomized controlled evaluation of HPV testing for cervical cancer screening |
| Stuart, Dr. Gavin C. | Merck Frost Canada Ltd. | A randomized, international, double-blinded (with in-house blinding), controlled with Gardasil, dose ranging, tolerability, immunogenicity and efficacy study of a multivalent human papillomavirus (HPV) L1 virus-like particle (VLP) vaccine administered to |
| Stuart, Dr. Gavin C. | CIHR - Operating Grant | A study of HPV-VLP Vaccine in a cohort of HIV positive girls and women |
| Stuart, Dr. Gavin C. | Merck Frost Canada Ltd. | A randomized, double-blinded, tolerability and immunogenicity study of a multivalent Human Papillomaviris (HPV) L1 Virus-Like Particle (VLP) vaccine (V504) administered concomitantly with Gardasil ™ to 16 - 26 year old women |
| von Dadelszen, Dr. Peter | Canadian Institutes of Health Research (CIHR) | Investigating severe maternal morbidity |
| von Dadelszen, Dr. Peter | CIHR - Genomic Medicine and Human Development Operating | Epigenetics and human reproductive health |
| von Dadelszen, Dr. Peter | CIHR - Randomized Controlled Trials | TIPPS (The thrombophillia in pregnancy prophylaxis study |
| von Dadelszen, Dr. Peter | MSFHR - Investigator Award - Senior Scholar | Pre-eclampsia: immunology, innovation, and improvement |
| von Dadelszen, Dr. Peter | CIHR - Operating Grant | MIREC (Maternal-Infant Research on Environment Chemicals) |
| von Dadelszen, Dr. Peter | CFRI - Investigator Award | Pre-eclampsia: from mechanisms modification |
| von Dadelszen, Dr. Peter | CIHR - Randomized Controlled Trials | CHIPS (Control of Hypertension in Pregnancy Study) |
| Wilkie, Dr. David H. | BC Health Care Research Foundation | Fellowship Grant |
